Serum Lactate Dehydrogenase Isoenzyme 1: An Early Indicator Of Relapse In Patients With Testicular Germ Cell Tumors
Open Access
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 34 (7) , 925-929
- https://doi.org/10.3109/02841869509127206
Abstract
The present study aimed to evaluate serum lactate dehydrogenase isoenzyme 1 (S-LD-1) as an indicator of relapse for patients with testicular germ cell tumors. Twenty-seven patients were investigated with repeated determinations of S-LD-1 from diagnosis to relapse; 9 had seminoma and 18 nonseminomatous tumors. Eleven of 21 had raised S-LD-1 at relapse (4 with seminoma). Seven of the 27 patients had a raised S-LD-1 for median 2 months (1.4–4.5 months) before relapse was detected. Thus, S-LD-1 is of use, complementary to clinical examinations, determinations of serum alpha fetoprotein and human chorionic gonadotropin, and CT scans, in monitoring patients with testicular germ cell tumors for relapse.Keywords
This publication has 6 references indexed in Scilit:
- 6.1.1.3 Analytical Bias by Contamination from Hemolysis in Determination of Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Testis Germ Cell TumorsUpsala Journal of Medical Sciences, 1993
- Surveillance following orchidectomy for stage I seminoma of the testisEuropean Journal Of Cancer, 1993
- Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumoursEuropean Journal Of Cancer, 1992
- Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group.Journal of Clinical Oncology, 1991
- Serum Lactate Dehydrogenase Isoenzyme 1 as a Marker of Testicular Germ Cell TumorJournal of Urology, 1988
- Tumour Markers in Testicular Germ Cell Tumours Five-Year Experience from the DATECA Study 1976–1980Acta Radiologica: Oncology, 1984